Gupta, P. K., Dutta, S., Kala, S., Nekkanti, M., Desai, S. C., Mahapatra, S. S., . . . Udaykumar, K. (2021). Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease. Wiley.
Style de citation Chicago (17e éd.)Gupta, Pawan Kumar, et al. Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease. Wiley, 2021.
Style de citation MLA (8e éd.)Gupta, Pawan Kumar, et al. Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease. Wiley, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.